一品红子公司获左卡尼汀口服溶液注册证书

Core Viewpoint - The company has received approval for the registration of L-Carnitine oral solution, which is indicated for the treatment of primary systemic carnitine deficiency [1] Group 1 - The company's wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has obtained the drug registration certificate from the National Medical Products Administration [1] - The approved product, L-Carnitine oral solution, addresses a specific medical condition, enhancing the company's product portfolio [1]